FDA/CDC

FDA authorizes COVID boosters for all U.S. adults


 

The Food and Drug Administration has given the green light to third, or booster doses of the Pfizer and Moderna vaccines for everyone over the age of 18, ahead of the busy winter holiday season.

“Authorizing the use of a single booster dose of either the Moderna or Pfizer-BioNTech COVID-19 vaccine for individuals 18 years of age and older helps to provide continued protection against COVID-19, including the serious consequences that can occur, such as hospitalization and death,” said acting FDA Commissioner Janet Woodcock, MD, in an FDA press statement.

The Center for Disease Control and Prevention’s Advisory Committee on Immunization Practices will meet on Nov. 19 to review the science supporting a more widespread need for booster doses, and is expected to vote on official recommendations for their use in the United States. The CDC director must then sign off on the panel’s recommendations.

“As soon as the FDA reviews those data and provides an authorization, we at CDC will act swiftly,” Rochelle P. Walensky, MD, MPH, said at a recent White House briefing.

Several states – including Louisiana, Maine, and Colorado – have already authorized boosters for all adults as cases rise in Europe and across the Western and Northeastern regions of the United States.

FDA officials said they hoped that widening eligibility for boosters would cut down on confusion for people and hopefully speed uptake of the shots.

“Streamlining the eligibility criteria and making booster doses available to all individuals 18 years of age and older will also help to eliminate confusion about who may receive a booster dose and ensure booster doses are available to all who may need one,” said Peter Marks, MD, PhD, who heads the FDA’s Center for Biologics Evaluation and Research.

A version of this article first appeared on WebMD.com.

Recommended Reading

Alcohol-related liver disease severity increased during COVID-19 pandemic
Federal Practitioner
Whistleblowers will play key role in enforcing workplace vaccine mandate
Federal Practitioner
COVID-19 vaccine mandates are working, public health experts say
Federal Practitioner
What to do about pandemic PTSD
Federal Practitioner
Pandemic stresses harder on physician moms than physician dads: Study
Federal Practitioner
Hantavirus 5-Point Screen Tool Identifies Patients With Deadly Infection
Federal Practitioner
New x-ray technique shows COVID-19 lung in unprecedented detail
Federal Practitioner
Should you worry about picking up COVID or other infections from public bathrooms?
Federal Practitioner
More tools for the COVID toolbox
Federal Practitioner
Mask-wearing cuts new COVID-19 cases by 53%, study says
Federal Practitioner